Last checked at 9 Feb 2022 16:02
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Indivior Share News (INDV)
INDV Share
Price
INDV Share
News
INDV Share
Chat
INDV Share
Trades2
INDV
Live RNS
INDV Share
Charts
INDV Level 2
Console
INDV Live
Share Price
INDV Broker
Ratings
INDV Directors
Deals
INDV Financial
Diary
INDV
Fundamentals
INDV Short
Positions
INDV
Media
Indivior Information
Share Price Information for Indivior (INDV)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,400.00
Bid:
0.00
Ask:
0.00
Change:
0.00 (0.00%)
Spread:
20.00 (1.439%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
1,400.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.28 Jan 2022 16:22
UPDATE: Indivior notes robust results for treatment in fentanyl trial
UPDATE: Indivior notes robust results for treatment in fentanyl trial
Read more28 Jan 2022 14:53
CORRECT: Indivior notes results for painkiller in fentanyl trial
CORRECT: Indivior notes results for painkiller in fentanyl trial
Read more28 Jan 2022 09:02
Indivior's painkiller demonstrates positive interaction with fentanyl
Indivior's painkiller demonstrates positive interaction with fentanyl
Read more28 Jan 2022 07:55
Indivior welcomes results from buprenorphine-fentanyl interaction study
(Sharecast News) - Pharmaceutical company Indivior hailed the results of a study aimed at assessing the ability of its buprenorphine asset to reduce respiratory depression and apnea associated with the synthetic opioid fentanyl.
Read more19 Nov 2021 14:56
EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair
EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair
Read more10 Nov 2021 12:28
LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data
LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data
Read more10 Nov 2021 10:12
IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million
IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million
Read more10 Nov 2021 08:07
Indivior slumps as Scopia Capital sells 20m shares
(Sharecast News) - Indivior was under the cosh on Wednesday after US alternative asset management firm Scopia Capital sold 20m shares in the opioid addiction treatment maker in a placing.
Read more1 Nov 2021 09:38
LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest
LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest
Read more28 Oct 2021 13:23
Indivior lifts 2021 revenue guidance amid strong Sublocade sales
Indivior lifts 2021 revenue guidance amid strong Sublocade sales
Read more28 Oct 2021 12:17
Indivior lifts FY guidance as Q3 profits, revenue jump
(Sharecast News) - Indivior lifted its full-year guidance on Thursday as it reported a rise in third-quarter revenue and profit.
Read more24 Oct 2021 17:12
Sunday share tips: Light Science Technologies, Indivior
(Sharecast News) - The Financial Mail on Sunday's Midas column told readers to buy shares of Light Science Technologies, pointing out the benefits of the company's technology for health, climate and the UK more economy.
Read more31 Aug 2021 09:38
LONDON BROKER RATINGS: Citi and JPMorgan differ on Bridgepoint
LONDON BROKER RATINGS: Citi and JPMorgan differ on Bridgepoint
Read more11 Aug 2021 16:08
Director dealings: Indivior director ups stake
(Sharecast News) - Indivior revealed on Wednesday that non-executive director Mark Stejbach had acquired 36,000 ordinary shares in the FTSE 250-listed pharmaceuticals business.
Read more